Profil
Shannon Inman worked as Vice President-Global Clinical Operations at Genprex, Inc. from 2020 to 2021.
Prior to that, she worked as Vice President-Global Clinical Operations at Kuur Therapeutics Ltd.
She also worked as a Project Manager at Baylor College of Medicine.
In terms of education, Inman received an undergraduate degree from Texas A&M University.
Ehemalige bekannte Positionen von Shannon Inman
Unternehmen | Position | Ende |
---|---|---|
GENPREX, INC. | Chief Tech/Sci/R&D Officer | 01.11.2021 |
Baylor College of Medicine | Corporate Officer/Principal | - |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Shannon Inman
Texas A&M University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GENPREX, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |